Fellowship · Jacksonville, FL
Sponsored by Mayo Clinic College of Medicine and Science
TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A.
Nature · 2022 · 466 citations · Bjorn Oskarsson
Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD.
Science translational medicine · 2024 · 158 citations · Bjorn Oskarsson
A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City.
Neurology · 2021 · 231 citations · Andre Granger
Single-cell dissection of the human motor and prefrontal cortices in ALS and FTLD.
Cell · 2024 · 81 citations · Bjorn Oskarsson
Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study.
The Lancet. Neurology · 2024 · 71 citations · Bjorn Oskarsson
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
The Lancet. Neurology · 2021 · 136 citations · Elizabeth Mauricio
Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
JAMA neurology · 2021 · 118 citations · Elizabeth Mauricio, Bjorn Oskarsson
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
JAMA · 2025 · 22 citations · Bjorn Oskarsson, Jaimin Shah